Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-017125

Chief Financial Officer sold 10,000 shares at $24.02 ($240,219)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Financial Officer 2021-04-23 Sale −10,000 $24.02 $240,219 75,638 D: show line 1 in the form
Open-market sales · 10,000 sh · avg $24.02 · $240,219
Loading xslF345X03/doc4.xml…